Cargando…
Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking
BACKGROUND: The outbreak of the novel coronavirus disease COVID-19, caused by the SARS-CoV-2 virus has spread rapidly around the globe during the past 3 months. As the virus infected cases and mortality rate of this disease is increasing exponentially, scientists and researchers all over the world a...
Autores principales: | Mohapatra, Sovesh, Nath, Prathul, Chatterjee, Manisha, Das, Neeladrisingha, Kalita, Deepjyoti, Roy, Partha, Satapathi, Soumitra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660547/ https://www.ncbi.nlm.nih.gov/pubmed/33180803 http://dx.doi.org/10.1371/journal.pone.0241543 |
Ejemplares similares
-
Highly sensitive and selective detection of dopamine with boron and sulfur co-doped graphene quantum dots
por: Chatterjee, Manisha, et al.
Publicado: (2022) -
Identifying the engagement of a brain network during a targeted tDCS-fMRI experiment using a machine learning approach
por: Shinde, Anant, et al.
Publicado: (2023) -
Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension
por: Saha, Sarama, et al.
Publicado: (2020) -
Rapidly progressive dementia in a case of progressive multifocal leukoencephalopathy
por: Daimary, Partha Pratim, et al.
Publicado: (2019) -
An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
por: Agrawal, Himanshu, et al.
Publicado: (2020)